These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 2382234

  • 1. Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody.
    Cosimi AB, Delmonico FL, Wright JK, Wee SL, Preffer FI, Jolliffe LK, Colvin RB.
    Surgery; 1990 Aug; 108(2):406-13; discussion 413-4. PubMed ID: 2382234
    [Abstract] [Full Text] [Related]

  • 2. Immunosuppression of cynomolgus renal allograft recipients with humanized OKT4A monoclonal antibodies.
    Delmonico FL, Knowles RW, Colvin RB, Cavender DE, Kawai T, Bedle M, Stroka D, Preffer FI, Haug C, Cosimi AB.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):784-5. PubMed ID: 8438479
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Anti-CD4 monoclonal antibody therapy.
    Delmonico FL, Cosimi AB.
    Clin Transplant; 1996 Oct; 10(5):397-403. PubMed ID: 8930451
    [Abstract] [Full Text] [Related]

  • 5. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts.
    Cosimi AB, Conti D, Delmonico FL, Preffer FI, Wee SL, Rothlein R, Faanes R, Colvin RB.
    J Immunol; 1990 Jun 15; 144(12):4604-12. PubMed ID: 1972162
    [Abstract] [Full Text] [Related]

  • 6. Humanized IgG1 and IgG4 anti-CD4 monoclonal antibodies: effects on lymphocytes in the blood, lymph nodes, and renal allografts in cynomolgus monkeys.
    Mourad GJ, Preffer FI, Wee SL, Powelson JA, Kawai T, Delmonico FL, Knowles RW, Cosimi AB, Colvin RB.
    Transplantation; 1998 Mar 15; 65(5):632-41. PubMed ID: 9521196
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a Cooperative Clinical Trials in Transplantation pilot study.
    Transplantation; 1997 Apr 27; 63(8):1087-95. PubMed ID: 9133469
    [Abstract] [Full Text] [Related]

  • 13. CDR-grafted OKT4A monoclonal antibody in cynomolgus renal allograft recipients.
    Powelson JA, Knowles RW, Delmonico FL, Kawai T, Mourad G, Preffer FK, Colvin RB, Cosimi AB.
    Transplantation; 1994 Mar 27; 57(6):788-93. PubMed ID: 7908767
    [Abstract] [Full Text] [Related]

  • 14. Immunologic monitoring with Orthoclone OKT3 therapy.
    Schroeder TJ, First MR, Hurtubise PE, Marmer DJ, Martin DM, Mansour ME, Melvin DB.
    J Heart Transplant; 1989 Mar 27; 8(5):371-80. PubMed ID: 2529358
    [Abstract] [Full Text] [Related]

  • 15. Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a cooperative clinical trials in transplantation pilot study. Cooperative Clinical Trials in Transplantation Research Group.
    Transplantation; 1997 May 15; 63(9):1243-51. PubMed ID: 9158016
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of the effects of TNF in renal allograft recipients using recombinant human dimeric tumor necrosis factor receptors.
    Eason JD, Wee S, Kawai T, Hong HZ, Powelson JA, Widmer MB, Cosimi AB.
    Transplantation; 1995 Jan 27; 59(2):300-5. PubMed ID: 7839455
    [Abstract] [Full Text] [Related]

  • 17. SV40 infection associated with rituximab treatment after kidney transplantation in nonhuman primates.
    Maki T, Carville A, Stillman IE, Sato K, Kodaka T, Minamimura K, Ogawa N, Kanamoto A, Gottschalk R, Monaco AP, Marr-Belvin A, Westmoreland SV, Sehgal P.
    Transplantation; 2008 Mar 27; 85(6):893-902. PubMed ID: 18360273
    [Abstract] [Full Text] [Related]

  • 18. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG, Huang EH, Bergese SD, Sedmak DD, Birmingham DJ, Ohye RG, VanBuskirk AM.
    J Heart Lung Transplant; 1997 Sep 27; 16(9):889-904. PubMed ID: 9322138
    [Abstract] [Full Text] [Related]

  • 19. Comparison of in vivo efficacy and mechanism of action of antimurine monoclonal antibodies directed against TCR alpha beta (H57-597) and CD3 (145-2C11).
    Henrickson M, Reid J, Bellet JS, Sawchuk SS, Hirsch R.
    Transplantation; 1995 Oct 27; 60(8):828-35. PubMed ID: 7482743
    [Abstract] [Full Text] [Related]

  • 20. Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients.
    Schroeder TJ, First MR, Mansour ME, Alexander JW, Penn I.
    Am J Kidney Dis; 1989 Nov 27; 14(5 Suppl 2):14-8. PubMed ID: 2510506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.